Concepedia

Felipe Reyes-Cosmelli

FR

Statistics

Publications

3

Citations

146

H-Index

3

Active since

2022

Affiliations

Fundación Arturo López Pérez(Current)

Hospital Universitari i Politècnic La Fe

Vall d'Hebron Hospital Universitari

Merck & Co., Inc., Rahway, NJ, USA (United States)

Felipe Reyes-Cosmelli is an author at Fundación Arturo López Pérez specializing in chemotherapy, oncology, and cancer immunotherapy.

Publications per year

2022–2025

3

Publications

3

First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations

Luis Paz‐Ares, Tudor–Eliade Ciuleanu, Manuel Cobo et al. · Journal of Thoracic Oncology · 2022 · 97 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial

Thomas Powles, Yen‐Hwa Chang, Yoshiaki Yamamoto et al. · Nature Medicine · 2024 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Jin Li, M. Fernández, Felipe Reyes-Cosmelli et al. · Journal of Clinical Oncology · 2025 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

1–3 of 3